CTOs on the Move

Intermountain Therapy Animals

www.therapyanimals.org

 
Intermountain Therapy Animals is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Artio Medical

ARTIO MEDICAL, formerly known as Metactive Medical, is developing innovative endovascular medical devices with the potential to provide immediate and lasting occlusion of aneurysms, blood vessels, and other vascular structures. Artio`s products enable precision placement and provide immediate, complete, and lasting occlusion of target vessel segments and saccular aneurysms. These products will enable physicians to perform better, faster, and safer vascular occlusion procedures.

RapidAI

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 4 million scans in more than 2000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money.

USB Medical

USB Medical is a Huntingdon Vy, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Specialty Commerce

Specialty Commerce is a West Bridgewater, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.